Byd Electronic Obtains Production License for E-Cigarettes in China

Aug.05.2022
BYD's subsidiary has obtained an e-cigarette manufacturing license, indicating its legal participation in the industry and potential competition.

In the past two years, with the successive release of new policies on electronic cigarette regulation, enterprises engaged in the production and operation of electronic cigarette products, vaporizers, and nicotine used in electronic cigarettes are required to obtain a production license, leading to some domestic electronic cigarette companies turning into the mainstream, and the electronic cigarette industry is moving towards a healthy and orderly development. Recently, BYD announced that it has obtained a production license, which means that BYD Electronics has officially participated in competition in the field of electronic cigarette OEMs with a legal identity.


BYD Electronics receives production license.


On August 4th, BYD Electronic announced on their official public account that their wholly-owned subsidiary, BYD Precision Manufacturing Co., Ltd., has been awarded a production license (for electronic cigarette processing enterprises) by the National Tobacco Monopoly Bureau. This means that BYD Electronic can now legally compete in the field of electronic cigarette processing.


BYD Electronic has announced that the company has completed the patent layout and automated production line for its full range of electronic atomization products. The company has integrated its own capabilities in new materials research and development, precision molds, product design and development, as well as intelligent manufacturing, with the goal of becoming a leader and practitioner in the field of health and harm reduction.


For A-share investors, BYD is best known for its new energy vehicles, to the extent that many people consider it to be just an auto company.


It is understood that BYD Electronic spun off from BYD and mainly engages in contract manufacturing of intelligent phones, masks, and e-cigarettes. As early as 2018, BYD Electronic has been laying out the e-cigarette business, and officially launched its ceramic atomization core (ceramic core) technology brand "BEEMCORE" in 2021.


It is worth mentioning that, on the morning of August 4th, BYD Electronic announced that it had been awarded a license to produce tobacco monopolies, and its stock price rose more than 12% at one point during the day, indicating the capital market's expectation for its electronic cigarette business.


Simaole's dominant market position may be challenged.


Aside from BYD Electronics, on the same day, SMIC announced on its official WeChat account, "SMIC Technology," that three fully-owned subsidiaries under the SMIC Group, Shenzhen McWalters Technology Co., Ltd., Shenzhen McBrother Technology Co., Ltd., and Shenzhen Weiplus Technology Co., Ltd., have been awarded the Tobacco Monopoly Bureau's production permits for tobacco monopoly enterprises. The issuance of these permits further strengthens SMIC's confidence in its future development, and the overall production and operation of the group will proceed according to the planned schedule.


It is undeniable that Smoore is currently the leading electronic cigarette company in China and even globally, and many institutions have high expectations for its development.


It is reported that in 2021, Smoore's global market share continued to expand to 22.8%, surpassing the total of the second to fifth places, and maintaining its position as the world's largest electronic atomization device manufacturer. However, Smoore's stock price has recently dropped significantly as investors believe that BYD and Luxshare Precision's entry into the industry will divide Smoore's market share and reduce their profitability.


However, industry insiders estimate that BYD's outsourcing capacity will not be too high, mainly because they are new to the industry and approved production capacity is mainly based on past business data. Some insiders have disclosed that the approved quantity for the pod is very low.


According to the "Regulations on the Management of Electronic Cigarettes" and related Q&A issued by the China National Tobacco Authority on March 11, 2022, anyone engaged in the production, wholesale, or retail of electronic cigarettes in China must obtain the relevant tobacco monopoly license. The regulations also specify that there will be a transition period from May 1, 2022 to September 30, 2022.


Starting from June, the government began conducting qualification and production capacity audits, which will continue until early October. This means that the production licenses and production capacity status of e-cigarette companies will be intensively disclosed in August and September. It is understood that both brand owners and factories are required to disclose their approved production capacity status.


Currently, it is a critical moment for license issuance. It is understood that regulatory agencies have established numerous teams to visit companies and conduct different types of inspections based on the industry. For example, for aerosol companies, the focus is on the completeness of licenses, compliance with site regulations, scientific manufacturing processes, quality control requirements, employee training and vocational education, as well as annual production capacity and sales history.


BYD Electronic stated that it will firmly support the national policies related to electronic cigarettes, operate its production in compliance with laws and regulations, and make positive contributions to the healthy and orderly development of the industry.


Simoer stated that in the future, they will continue to adhere to regulatory requirements and promote standardized, orderly development. They will also firmly support related national policies and operate in compliance with the law. Simultaneously, they will use scientific and technological innovation as the driving force for enterprise development, actively promote the long-term, healthy development of the industry, serve global customers and users, and fulfill their corporate responsibilities to contribute positively to society.


This article contains excerpts or reproductions of third-party information and its copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual who needs to reprint, please contact the author and do not reprint directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City's Department of Consumer and Worker Protection (DCWP) opened applications on November 2, 2026, for a lottery covering tobacco and electronic cigarette retail dealer licenses, with a deadline of 5 p.m. New York local time on November 30. According to the city's October 1 notice, 55 electronic cigarette retail license slots are available across 23 community districts, including 28 in Brooklyn, alongside 322 tobacco retail license slots across 41 districts. Businesses must enter the lottery and, if invited, complete licensing requirements within 65 days. New York City continues to restrict e-cigarette retail sales to tobacco-flavored or unflavored products, while city retail licenses do not replace FDA product marketing authorization.
Market
Nov.04
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08